European Investment Bank Africa

SA’s Biovac wins $108m to build Africa’s vaccine factory

Cape Town’s Biovac has secured €75 million from the EIB and $20 million from the IFC to build Africa’s first end-to-end multi-vaccine manufacturing facility, producing 400 million doses annually by 2028 and closing 40%…